Gamal Chehab

1.3k total citations
58 papers, 657 citations indexed

About

Gamal Chehab is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Gamal Chehab has authored 58 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Rheumatology, 24 papers in Immunology and 11 papers in Pathology and Forensic Medicine. Recurrent topics in Gamal Chehab's work include Systemic Lupus Erythematosus Research (28 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). Gamal Chehab is often cited by papers focused on Systemic Lupus Erythematosus Research (28 papers), Rheumatoid Arthritis Research and Therapies (15 papers) and Autoimmune and Inflammatory Disorders Research (9 papers). Gamal Chehab collaborates with scholars based in Germany, United States and Italy. Gamal Chehab's co-authors include Matthias Schneider, Jutta Richter, Rebecca Fischer‐Betz, Ralph Brinks, Oliver Sander, B. Winkler-Rohlfing, Anna Kernder, Stefan Vordenbäumen, Martin Aringer and Christof Specker and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

Gamal Chehab

53 papers receiving 649 citations

Peers

Gamal Chehab
Hani Almoallim Saudi Arabia
Kok Yong Fong Singapore
Manjari Lahiri Singapore
Rebecca E. Sadun United States
J. Patricia Dhar United States
Ángel M. Mayor Puerto Rico
Hani Almoallim Saudi Arabia
Gamal Chehab
Citations per year, relative to Gamal Chehab Gamal Chehab (= 1×) peers Hani Almoallim

Countries citing papers authored by Gamal Chehab

Since Specialization
Citations

This map shows the geographic impact of Gamal Chehab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gamal Chehab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gamal Chehab more than expected).

Fields of papers citing papers by Gamal Chehab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gamal Chehab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gamal Chehab. The network helps show where Gamal Chehab may publish in the future.

Co-authorship network of co-authors of Gamal Chehab

This figure shows the co-authorship network connecting the top 25 collaborators of Gamal Chehab. A scholar is included among the top collaborators of Gamal Chehab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gamal Chehab. Gamal Chehab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knitza, Johannes, Martin Krusche, Gamal Chehab, Christof Specker, & Jutta Richter. (2024). Digitale Gesundheitsanwendungen – was sollten wir als Rheumatolog:innen wissen. Zeitschrift für Rheumatologie. 83(10). 859–865. 3 indexed citations
3.
Mücke, Johanna, et al.. (2023). Defining the physician global assessment threshold equivalent to remission in patients with systemic lupus erythematosus. Lara D. Veeken. 63(6). 1649–1655. 1 indexed citations
4.
Kernder, Anna, K. Thiele, Gamal Chehab, Matthias Schneider, & Johanna Callhoff. (2023). Time interval between the onset of connective tissue disease symptoms and first contact with a rheumatologist: results from the German National Database of collaborative arthritis centers. Rheumatology International. 43(8). 1453–1458. 4 indexed citations
5.
Kernder, Anna, Kirsten de Groot, Bernhard Hellmich, et al.. (2023). COVID-19 pandemic impairs medical care of vasculitis patients in Germany: Results of a national patient survey. Frontiers in Medicine. 9. 1103694–1103694. 2 indexed citations
6.
Richter, Jutta, et al.. (2022). Digitalization and disruptive change in rheumatology. Zeitschrift für Rheumatologie. 82(5). 417–424. 2 indexed citations
7.
Vordenbäumen, Stefan, Eugen Feist, Jürgen Rech, et al.. (2022). Leitlinienreport zur DGRh-S2e-Leitlinie Diagnostik und Therapie des adulten Still-Syndroms (AOSD). Zeitschrift für Rheumatologie. 81(S1). 21–27. 3 indexed citations
8.
Richter, Jutta, Gamal Chehab, Peer Aries, et al.. (2022). Evaluation of the use of video consultation in German rheumatology care before and during the COVID-19 pandemic. Frontiers in Medicine. 9. 1052055–1052055. 9 indexed citations
9.
Richter, Jutta, et al.. (2022). One year of digital health applications (DiGA) in Germany – Rheumatologists’ perspectives. Frontiers in Medicine. 9. 1000668–1000668. 26 indexed citations
10.
Haase, Isabell, Gamal Chehab, Oliver Sander, Matthias Schneider, & Rebecca Fischer‐Betz. (2021). AB0341 SLE PREGNANCIES AT HIGH RISK FOR PRE-ECLAMPSIA BENEFIT MOST FROM COMBINATION OF LOW DOSE ASPIRIN AND HYDROXYCHLOROQUINE. Annals of the Rheumatic Diseases. 80. 1195–1196. 2 indexed citations
11.
Aries, Peer, Martin Welcker, Johanna Callhoff, et al.. (2020). Stellungnahme der Deutschen Gesellschaft für Rheumatologie e. V. (DGRh) zur Anwendung der Videosprechstunde in der Rheumatologie. Zeitschrift für Rheumatologie. 79(10). 1078–1085. 16 indexed citations
12.
Knitza, Johannes, Johanna Callhoff, Gamal Chehab, et al.. (2020). Positionspapier der Kommission Digitale Rheumatologie der Deutschen Gesellschaft für Rheumatologie e. V.: Aufgaben, Ziele und Perspektiven für eine moderne Rheumatologie. Zeitschrift für Rheumatologie. 79(6). 562–569. 19 indexed citations
13.
Mücke, Johanna, Ralph Brinks, Rebecca Fischer‐Betz, et al.. (2019). <p>Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections</p>. Patient Preference and Adherence. Volume 13. 1889–1894. 6 indexed citations
14.
Vordenbäumen, Stefan, Ralph Brinks, Oliver Sander, et al.. (2019). Determinanten gesundheitsbezogener Lebensqualität bei systemischem Lupus erythematodes: eine monozentrische, retrospektive Langzeitobservationsstudie in Deutschland. Zeitschrift für Rheumatologie. 78(9). 813–819. 2 indexed citations
15.
Doria, Andrea, Ricard Cervera, Mariele Gatto, Gamal Chehab, & Matthias Schneider. (2017). The new targeted therapy in systemic lupus erythematosus: Is the glass half-full or half-empty?. Autoimmunity Reviews. 16(11). 1119–1124. 10 indexed citations
16.
Chehab, Gamal, et al.. (2014). Selbst-Monitoring bei entzündlich-rheumatischen Erkrankungen. Zeitschrift für Rheumatologie. 73(8). 706–713. 1 indexed citations
17.
Fischer‐Betz, Rebecca, Gamal Chehab, Oliver Sander, et al.. (2012). Renal Outcome in Patients with Lupus Nephritis Using a Steroid-free Regimen of Monthly Intravenous Cyclophosphamide: A Prospective Observational Study. The Journal of Rheumatology. 39(11). 2111–2117. 33 indexed citations
18.
Chehab, Gamal, Rebecca Fischer‐Betz, & Matthias Schneider. (2011). Entwicklung von Mortalität und Morbidität beim systemischen Lupus erythematodes. Zeitschrift für Rheumatologie. 70(6). 480–485. 20 indexed citations
19.
Vordenbäumen, Stefan, Ellen Bleck, Jutta Richter, et al.. (2010). Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener’s granulomatosis. Rheumatology International. 31(9). 1251–1254. 11 indexed citations
20.
Chehab, Gamal, Oliver Sander, Rebecca Fischer‐Betz, & Matthias Schneider. (2007). Anti-CD20-Therapie zur Remissionsinduktion und -erhaltung bei therapierefraktärem systemischen Lupus erythematodes. Zeitschrift für Rheumatologie. 66(4). 328–336. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026